Exploring Mechanisms and Morphology of QT Interval Prolongation
Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The projects will try and optimise the risk stratification for patients with Long QT syndrome
by investigating how the exposure of physical and acoustic stress will affect the QT-dynamics
and if beta blockers protect against arrhythmias by suppressing this dynamic QT-prolongation.
Furthermore, the project will investigate the effects of Spironolactone on the QT-dynamics
tested by "Brisk Standing".
First, patients are tested with known arrhythmic triggers and they are then administered
thier normal dose of beta blockers. Hereafter, "Brisk Standing" test is performed and the
patients are on Spironolactone for seven days. After seven days treatment the "Brisk
Standing" is repeated.